Does Rallies show Form 4 insider transactions for VBIO?

Yes. Rallies tracks VBIO insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is VBIO research on Rallies investment advice?

No. Rallies provides research, data, and educational context for VBIO. It does not provide personalized investment advice.

VBIO (Valion Bio, Inc. Common Stock) Stock Analysis - Insider Trades

Valion Bio, Inc. Common Stock (VBIO) is a publicly traded the market company. As of May 21, 2026, VBIO trades at $0.85 with a market cap of $2.70M and a P/E ratio of 0.00. VBIO moved +0.00% today. Year to date, VBIO is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.80 to $1.21. Rallies surfaces VBIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading VBIO stock inside the company?

Recent VBIO insider activity includes LoConti Joseph E. bought 1.00K, LoConti Joseph E. bought 13.00K, LoConti Joseph E. bought 40.00K, LoConti Joseph E. bought 67.00K, and LoConti Joseph E. bought 20.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

VBIO Key Metrics

Key financial metrics for VBIO
Metric	Value
Price	$0.85
Market Cap	$2.70M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$1.21
52-Week Low	$0.80
Volume	1.88K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

Recent VBIO Insider Trades

LoConti Joseph E. bought 1.00K (~$200) on Jul 29, 2021.
LoConti Joseph E. bought 13.00K (~$2.60K) on Jul 20, 2021.
LoConti Joseph E. bought 40.00K (~$6.40K) on Jul 19, 2021.
LoConti Joseph E. bought 67.00K (~$12.73K) on Jul 19, 2021.
LoConti Joseph E. bought 20.00K (~$4.00K) on Jul 19, 2021.

Latest VBIO News

Valion Bio Q1 Operating Expenses Climb to $5.6 M; Entolimod Scale-Up Advances — May 14, 2026
Valion Bio Opens San Antonio Biomanufacturing Plant with 45 Staff Supporting Entolimod — May 6, 2026
Valion Bio Appoints Veteran Counsel Ahead of Entolimod FDA Animal Rule Push — May 4, 2026

VBIO Analyst Consensus

VBIO analyst coverage data. Average price target: $0.00.

Common questions about VBIO

Who is trading VBIO stock inside the company?: Recent VBIO insider activity includes LoConti Joseph E. bought 1.00K, LoConti Joseph E. bought 13.00K, LoConti Joseph E. bought 40.00K, LoConti Joseph E. bought 67.00K, and LoConti Joseph E. bought 20.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for VBIO?: Yes. Rallies tracks VBIO insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is VBIO research on Rallies investment advice?: No. Rallies provides research, data, and educational context for VBIO. It does not provide personalized investment advice.